カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のGLP-1RA医薬品市場2023年：企業・地域・タイプ・用途別分析

■ 英語タイトル：Global GLP-1RA Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23SM7865）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23SM7865
■ 発行日：2023年9月
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：97
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のGLP-1RA医薬品市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

GlobalInfoResearchの最新の調査によると、世界のGLP-1RA医薬品の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のGLP-1RA医薬品市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- GLP-1RA医薬品の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

GLP-1RA医薬品市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・経口錠剤、注射剤

用途別セグメント
・低血糖、体重減少、その他

主要な市場プレーヤー
・Novo Nordisk、Eli Lilly And Company、AstraZeneca、Merck、Innovent Biologics、Daoer Bio

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、GLP-1RA医薬品製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なGLP-1RA医薬品メーカーの企業概要、2019年～2022年までのGLP-1RA医薬品の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なGLP-1RA医薬品メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別GLP-1RA医薬品の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのGLP-1RA医薬品のタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのGLP-1RA医薬品市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびGLP-1RA医薬品の産業チェーンを掲載しています。
・第14、15章では、GLP-1RA医薬品の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– GLP-1RA医薬品の概要
– タイプ別分析（2018年vs2022年vs2029年）：経口錠剤、注射剤
– 用途別分析（2018年vs2022年vs2029年）：低血糖、体重減少、その他
– 世界のGLP-1RA医薬品市場規模・予測
– 世界のGLP-1RA医薬品生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Novo Nordisk、Eli Lilly And Company、AstraZeneca、Merck、Innovent Biologics、Daoer Bio
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：経口錠剤、注射剤
・用途別分析2018年-2029年：低血糖、体重減少、その他
・GLP-1RA医薬品の北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・GLP-1RA医薬品のヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・GLP-1RA医薬品のアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・GLP-1RA医薬品の南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・GLP-1RA医薬品の中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of GLP-1RA Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global GLP-1RA Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Oral Tablets
1.3.3 Injection
1.4 Market Analysis by Application
1.4.1 Overview: Global GLP-1RA Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hypoglycemia
1.4.3 Weight Loss
1.4.4 Other
1.5 Global GLP-1RA Drugs Market Size & Forecast
1.5.1 Global GLP-1RA Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global GLP-1RA Drugs Sales Quantity (2018-2029)
1.5.3 Global GLP-1RA Drugs Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk GLP-1RA Drugs Product and Services
2.1.4 Novo Nordisk GLP-1RA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novo Nordisk Recent Developments/Updates
2.2 Eli Lilly And Company
2.2.1 Eli Lilly And Company Details
2.2.2 Eli Lilly And Company Major Business
2.2.3 Eli Lilly And Company GLP-1RA Drugs Product and Services
2.2.4 Eli Lilly And Company GLP-1RA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Eli Lilly And Company Recent Developments/Updates
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca GLP-1RA Drugs Product and Services
2.3.4 AstraZeneca GLP-1RA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 AstraZeneca Recent Developments/Updates
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck GLP-1RA Drugs Product and Services
2.4.4 Merck GLP-1RA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck Recent Developments/Updates
2.5 Innovent Biologics
2.5.1 Innovent Biologics Details
2.5.2 Innovent Biologics Major Business
2.5.3 Innovent Biologics GLP-1RA Drugs Product and Services
2.5.4 Innovent Biologics GLP-1RA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Innovent Biologics Recent Developments/Updates
2.6 Daoer Bio
2.6.1 Daoer Bio Details
2.6.2 Daoer Bio Major Business
2.6.3 Daoer Bio GLP-1RA Drugs Product and Services
2.6.4 Daoer Bio GLP-1RA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Daoer Bio Recent Developments/Updates
3 Competitive Environment: GLP-1RA Drugs by Manufacturer
3.1 Global GLP-1RA Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global GLP-1RA Drugs Revenue by Manufacturer (2018-2023)
3.3 Global GLP-1RA Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of GLP-1RA Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 GLP-1RA Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 GLP-1RA Drugs Manufacturer Market Share in 2022
3.5 GLP-1RA Drugs Market: Overall Company Footprint Analysis
3.5.1 GLP-1RA Drugs Market: Region Footprint
3.5.2 GLP-1RA Drugs Market: Company Product Type Footprint
3.5.3 GLP-1RA Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global GLP-1RA Drugs Market Size by Region
4.1.1 Global GLP-1RA Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global GLP-1RA Drugs Consumption Value by Region (2018-2029)
4.1.3 Global GLP-1RA Drugs Average Price by Region (2018-2029)
4.2 North America GLP-1RA Drugs Consumption Value (2018-2029)
4.3 Europe GLP-1RA Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific GLP-1RA Drugs Consumption Value (2018-2029)
4.5 South America GLP-1RA Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa GLP-1RA Drugs Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global GLP-1RA Drugs Sales Quantity by Type (2018-2029)
5.2 Global GLP-1RA Drugs Consumption Value by Type (2018-2029)
5.3 Global GLP-1RA Drugs Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global GLP-1RA Drugs Sales Quantity by Application (2018-2029)
6.2 Global GLP-1RA Drugs Consumption Value by Application (2018-2029)
6.3 Global GLP-1RA Drugs Average Price by Application (2018-2029)
7 North America
7.1 North America GLP-1RA Drugs Sales Quantity by Type (2018-2029)
7.2 North America GLP-1RA Drugs Sales Quantity by Application (2018-2029)
7.3 North America GLP-1RA Drugs Market Size by Country
7.3.1 North America GLP-1RA Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America GLP-1RA Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe GLP-1RA Drugs Sales Quantity by Type (2018-2029)
8.2 Europe GLP-1RA Drugs Sales Quantity by Application (2018-2029)
8.3 Europe GLP-1RA Drugs Market Size by Country
8.3.1 Europe GLP-1RA Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe GLP-1RA Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific GLP-1RA Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific GLP-1RA Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific GLP-1RA Drugs Market Size by Region
9.3.1 Asia-Pacific GLP-1RA Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific GLP-1RA Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America GLP-1RA Drugs Sales Quantity by Type (2018-2029)
10.2 South America GLP-1RA Drugs Sales Quantity by Application (2018-2029)
10.3 South America GLP-1RA Drugs Market Size by Country
10.3.1 South America GLP-1RA Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America GLP-1RA Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa GLP-1RA Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa GLP-1RA Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa GLP-1RA Drugs Market Size by Country
11.3.1 Middle East & Africa GLP-1RA Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa GLP-1RA Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 GLP-1RA Drugs Market Drivers
12.2 GLP-1RA Drugs Market Restraints
12.3 GLP-1RA Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of GLP-1RA Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of GLP-1RA Drugs
13.3 GLP-1RA Drugs Production Process
13.4 GLP-1RA Drugs Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 GLP-1RA Drugs Typical Distributors
14.3 GLP-1RA Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global GLP-1RA Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global GLP-1RA Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 4. Novo Nordisk Major Business
Table 5. Novo Nordisk GLP-1RA Drugs Product and Services
Table 6. Novo Nordisk GLP-1RA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novo Nordisk Recent Developments/Updates
Table 8. Eli Lilly And Company Basic Information, Manufacturing Base and Competitors
Table 9. Eli Lilly And Company Major Business
Table 10. Eli Lilly And Company GLP-1RA Drugs Product and Services
Table 11. Eli Lilly And Company GLP-1RA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Eli Lilly And Company Recent Developments/Updates
Table 13. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 14. AstraZeneca Major Business
Table 15. AstraZeneca GLP-1RA Drugs Product and Services
Table 16. AstraZeneca GLP-1RA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. AstraZeneca Recent Developments/Updates
Table 18. Merck Basic Information, Manufacturing Base and Competitors
Table 19. Merck Major Business
Table 20. Merck GLP-1RA Drugs Product and Services
Table 21. Merck GLP-1RA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Merck Recent Developments/Updates
Table 23. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 24. Innovent Biologics Major Business
Table 25. Innovent Biologics GLP-1RA Drugs Product and Services
Table 26. Innovent Biologics GLP-1RA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Innovent Biologics Recent Developments/Updates
Table 28. Daoer Bio Basic Information, Manufacturing Base and Competitors
Table 29. Daoer Bio Major Business
Table 30. Daoer Bio GLP-1RA Drugs Product and Services
Table 31. Daoer Bio GLP-1RA Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Daoer Bio Recent Developments/Updates
Table 33. Global GLP-1RA Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 34. Global GLP-1RA Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 35. Global GLP-1RA Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 36. Market Position of Manufacturers in GLP-1RA Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 37. Head Office and GLP-1RA Drugs Production Site of Key Manufacturer
Table 38. GLP-1RA Drugs Market: Company Product Type Footprint
Table 39. GLP-1RA Drugs Market: Company Product Application Footprint
Table 40. GLP-1RA Drugs New Market Entrants and Barriers to Market Entry
Table 41. GLP-1RA Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global GLP-1RA Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 43. Global GLP-1RA Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 44. Global GLP-1RA Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 45. Global GLP-1RA Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 46. Global GLP-1RA Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 47. Global GLP-1RA Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 48. Global GLP-1RA Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 49. Global GLP-1RA Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 50. Global GLP-1RA Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 51. Global GLP-1RA Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 52. Global GLP-1RA Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. Global GLP-1RA Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. Global GLP-1RA Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 55. Global GLP-1RA Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 56. Global GLP-1RA Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 57. Global GLP-1RA Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 58. Global GLP-1RA Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 59. Global GLP-1RA Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 60. North America GLP-1RA Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 61. North America GLP-1RA Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 62. North America GLP-1RA Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 63. North America GLP-1RA Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 64. North America GLP-1RA Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 65. North America GLP-1RA Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 66. North America GLP-1RA Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 67. North America GLP-1RA Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 68. Europe GLP-1RA Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Europe GLP-1RA Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Europe GLP-1RA Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 71. Europe GLP-1RA Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 72. Europe GLP-1RA Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 73. Europe GLP-1RA Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 74. Europe GLP-1RA Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe GLP-1RA Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific GLP-1RA Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 77. Asia-Pacific GLP-1RA Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 78. Asia-Pacific GLP-1RA Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 79. Asia-Pacific GLP-1RA Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 80. Asia-Pacific GLP-1RA Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 81. Asia-Pacific GLP-1RA Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 82. Asia-Pacific GLP-1RA Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 83. Asia-Pacific GLP-1RA Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 84. South America GLP-1RA Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 85. South America GLP-1RA Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 86. South America GLP-1RA Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 87. South America GLP-1RA Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 88. South America GLP-1RA Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 89. South America GLP-1RA Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 90. South America GLP-1RA Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 91. South America GLP-1RA Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 92. Middle East & Africa GLP-1RA Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 93. Middle East & Africa GLP-1RA Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 94. Middle East & Africa GLP-1RA Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Middle East & Africa GLP-1RA Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Middle East & Africa GLP-1RA Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 97. Middle East & Africa GLP-1RA Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 98. Middle East & Africa GLP-1RA Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 99. Middle East & Africa GLP-1RA Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 100. GLP-1RA Drugs Raw Material
Table 101. Key Manufacturers of GLP-1RA Drugs Raw Materials
Table 102. GLP-1RA Drugs Typical Distributors
Table 103. GLP-1RA Drugs Typical Customers
List of Figures
Figure 1. GLP-1RA Drugs Picture
Figure 2. Global GLP-1RA Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global GLP-1RA Drugs Consumption Value Market Share by Type in 2022
Figure 4. Oral Tablets Examples
Figure 5. Injection Examples
Figure 6. Global GLP-1RA Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global GLP-1RA Drugs Consumption Value Market Share by Application in 2022
Figure 8. Hypoglycemia Examples
Figure 9. Weight Loss Examples
Figure 10. Other Examples
Figure 11. Global GLP-1RA Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global GLP-1RA Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global GLP-1RA Drugs Sales Quantity (2018-2029) & (K Units)
Figure 14. Global GLP-1RA Drugs Average Price (2018-2029) & (US$/Unit)
Figure 15. Global GLP-1RA Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global GLP-1RA Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of GLP-1RA Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 GLP-1RA Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 GLP-1RA Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global GLP-1RA Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global GLP-1RA Drugs Consumption Value Market Share by Region (2018-2029)
Figure 22. North America GLP-1RA Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe GLP-1RA Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific GLP-1RA Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. South America GLP-1RA Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa GLP-1RA Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. Global GLP-1RA Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global GLP-1RA Drugs Consumption Value Market Share by Type (2018-2029)
Figure 29. Global GLP-1RA Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global GLP-1RA Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global GLP-1RA Drugs Consumption Value Market Share by Application (2018-2029)
Figure 32. Global GLP-1RA Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America GLP-1RA Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America GLP-1RA Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America GLP-1RA Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America GLP-1RA Drugs Consumption Value Market Share by Country (2018-2029)
Figure 37. United States GLP-1RA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada GLP-1RA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico GLP-1RA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe GLP-1RA Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe GLP-1RA Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe GLP-1RA Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe GLP-1RA Drugs Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany GLP-1RA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France GLP-1RA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom GLP-1RA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia GLP-1RA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy GLP-1RA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific GLP-1RA Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific GLP-1RA Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific GLP-1RA Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific GLP-1RA Drugs Consumption Value Market Share by Region (2018-2029)
Figure 53. China GLP-1RA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan GLP-1RA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea GLP-1RA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India GLP-1RA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia GLP-1RA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia GLP-1RA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America GLP-1RA Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America GLP-1RA Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America GLP-1RA Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America GLP-1RA Drugs Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil GLP-1RA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina GLP-1RA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa GLP-1RA Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa GLP-1RA Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa GLP-1RA Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa GLP-1RA Drugs Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey GLP-1RA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt GLP-1RA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia GLP-1RA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa GLP-1RA Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. GLP-1RA Drugs Market Drivers
Figure 74. GLP-1RA Drugs Market Restraints
Figure 75. GLP-1RA Drugs Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of GLP-1RA Drugs in 2022
Figure 78. Manufacturing Process Analysis of GLP-1RA Drugs
Figure 79. GLP-1RA Drugs Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の心筋梗塞治療薬市場2023年：企業・地域・タイプ・用途別分析
  • 世界の頸椎症治療薬市場2023年：企業・地域・タイプ・用途別分析
  • 世界の神経芽腫に対する化学療法薬市場2023年：企業・地域・タイプ・用途別分析
  • 世界のNSAID点眼薬市場2023年：企業・地域・タイプ・用途別分析
  • 世界の眼科用非ステロイド性抗炎症薬市場2023年：企業・地域・タイプ・用途別分析
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23SM7865 )"世界のGLP-1RA医薬品市場2023年：企業・地域・タイプ・用途別分析" (英文：Global GLP-1RA Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。